Article
The nitric oxide-donor molsidomine modulates the innate inflammatory response in a mouse model of muscular dystrophy.
European journal of pharmacology - 5 Sept 2013
Zordan Paola, Sciorati Clara, Campana Lara, Cottone Lucia, Clementi Emilio, Querini Patrizia-Rovere, Brunelli Silvia
Abstract excerpt
Inflammation plays a crucial role in muscle remodeling and repair after acute and chronic damage, in particular in muscular dystrophies, a heterogeneous group of genetic diseases leading to muscular degeneration. Defect of nitric oxide (NO) generation is a key pathogenic event in muscular dystrophies, thus NO donors have been explored as new therapeutics for this disease. We have investigated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
